IMAGING SCIENCE AND PHOTOCHEMISTRY ›› 2022, Vol. 40 ›› Issue (5): 1158-1163.DOI: 10.7517/issn.1674-0475.220405

• Review and Articles • Previous Articles     Next Articles

Effect of Yibuweibao Decoction Combined with Ziwu Liuzhu Acupuncture on Treating Chronic Gastritis

HAO Jie1,3, HUANG Yunman1, HUO Yongli1,3, LI Bolin1,2, SUN Runxue1, YIN Lu1, CHEN Xian1   

  1. 1. Hebei Province Chinese Medicine Hospital, Shijiazhuang 050013, Hebei, P. R. China;
    2. Key Laboratory of Integrated Chinese and Western Medicine for Gastroenterology, Zhangjiakou 076450, Hebei, P. R. China;
    3. Hebei Technology Innovation Center of TCM Spleen and Kidney Diseases, Langfang 065399, Hebei, P. R. China
  • Received:2022-04-26 Published:2022-09-13

Abstract: This study investigated the effect of Yibuweibao Decoction combined with Ziwu Liuzhu acupuncture on gastroscopic indexes of patients with chronic gastritis. Selected 136 patients with chronic gastritis and divided them into the control group (routine western medicine) and acupuncture drug combination group (plus Yibuweibao Decoction combined with Ziwu Liuzhu acupuncture) according simple random method with principle of 1:1. Pepsinogen subsets, inflammatory factors were compared between the two groups, and the difference of traditional Chinese medicine(TCM)symptom score, quality of life score, the curative effect and safety were observed. After treatment, the total effective rate in the acupuncture drug combination group was significantly higher than that in the control group (P<0.05). The TCM symptoms in the acupuncture and medicine combination group were significantly lower than those in the control group, and the score of quality of life was significantly higher than those of the control group (P<0.05). Pepsinogen II (PGII), Soluble Interleukin-2 Receptor (sIL-2R), Chemokine-1 (MCP-1) and Tumor Necrosis Factor-α (TNF-α) after treatment in the two groups were both lower than before treatment, the PepsinogenⅠ (PGⅠ) and PGⅠ/PGⅡ were higher than before treatment, and the improvement of pepsinogen subsets and inflammatory factors in the acupuncture drug combination group were significantly better than those in the control group (P<0.05). The improvement of gastroscopic symptoms in the acupuncture drug combination group was significantly better than that in the control group (P<0.05). There was no significant difference in adverse reactions between the two groups (P>0.05). Yibuweibao decoction combined with Ziwu Liuzhu acupuncture in the treatment of chronic gastritis can regulate the expression of pepsinogen subsets and inflammatory factors, and also can improve the performance of the symptoms under gastroscopy, and has high safety.

Key words: Yibuweibao Decoction, Ziwu Liuzhu acupuncture, chronic gastritis, pepsinogen subgroup